Inozyme Pharma, Inc.
INZY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21,081 | $34,588 | $32,915 | $23,316 |
| Short-Term Investments | $92,006 | $154,001 | $94,951 | $88,485 |
| Receivables | $467 | $385 | $115 | $62 |
| Inventory | $0 | $0 | -$115 | -$62 |
| Other Curr. Assets | $7,122 | $7,276 | $3,412 | $3,479 |
| Total Curr. Assets | $120,676 | $196,250 | $131,393 | $115,342 |
| Property Plant & Equip (Net) | $1,346 | $2,592 | $3,638 | $4,436 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $354 | $354 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,160 | $2,005 | $3,810 | $3,409 |
| Total NC Assets | $2,506 | $4,597 | $7,802 | $8,199 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $123,182 | $200,847 | $139,195 | $123,541 |
| Liabilities | – | – | – | – |
| Payables | $2,530 | $1,166 | $2,544 | $2,394 |
| Short-Term Debt | $15,415 | $910 | $1,632 | $1,462 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $3,810 | $0 |
| Other Curr. Liab. | $15,953 | $12,610 | $10,539 | $7,777 |
| Total Curr. Liab. | $33,898 | $14,686 | $14,715 | $11,633 |
| LT Debt | $31,458 | $45,682 | $5,962 | $2,640 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $124 | $0 |
| Total NC Liab. | $31,458 | $45,682 | $6,086 | $2,640 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $913 | $1,823 | $2,639 | $3,371 |
| Total Liabilities | $65,356 | $60,368 | $20,801 | $14,273 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $6 | $6 | $4 | $2 |
| Retained Earnings | -$387,954 | -$285,930 | -$214,761 | -$147,700 |
| AOCI | $69 | $41 | -$205 | $18 |
| Other Equity | $445,705 | $426,362 | $333,356 | $256,948 |
| Total Equity | $57,826 | $140,479 | $118,595 | $109,268 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $123,182 | $200,847 | $139,396 | $123,541 |
| Net Debt | $25,792 | $12,004 | -$25,321 | -$19,214 |